For example, it was shown in a recent meta-analysis that Dabigatran use had decreased risk of MH compared to VKA use, although this result did not reach statistical significance, that Rivaroxaban use had similar risk compared to VKA use and that Apixaban use had lower risk compared to VKA use [ 21 ].
← all excerpts
Major Hemorrhage Risk Associated with Direct Oral Anticoagulants in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis.
1
—
—